CTTI Seeks Investigator Input on Leveraging Mobile Technology in Trials

The Clinical Trials Transformation Initiative (CTTI) is asking investigators to share their perspectives on the use of mobile technology in research.

The findings will inform the development of recommendations for the research enterprise on incorporating mobile technology in clinical trials research. CTTI is a public-private partnership co-founded by the U.S. Food and Drug Administration and Duke University, with more than 80 member organizations representing diverse stakeholders in the clinical trials enterprise.

Participants will take part in a 90-minute, one-on-one telephone interview with a trained interviewer. CTTI seeks investigators who have used mobile devices for objective data collection (e.g., activity trackers) in interventional or observational clinical research.

CTTI has been active on other fronts, too. For example, earlier this year it unveiled a research project aimed at understanding patient perspectives on trials using mobile technology. CTTI has also developed three other related projects looking at other aspects of mobile trials (devices, novel endpoints, and legal/regulatory considerations).

For more information about opportunities to participate in the most current investigator-related research project, contact zachary.hallinan@duke.edu.

Related Links

Innovating Clinical Trials With Mobile Technology

Stakeholder Perceptions of the Use of Mobile Technology in Clinical Trials Project Overview